3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
113
Urinary Bladder Neoplasms
56
Carcinoma, Non-Small-Cell Lung
52
Cholangiocarcinoma
33
Biliary Tract Neoplasms
32
Neoplasm Metastasis
30
Ovarian Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
26
Breast Neoplasms
25
Lung Neoplasms
24
Neoplasms
23
Carcinoma, Transitional Cell
23
Triple Negative Breast Neoplasms
22
Nasopharyngeal Carcinoma
21
Colorectal Neoplasms
20
Recurrence
17
Non-Muscle Invasive Bladder Neoplasms
16
Gallbladder Neoplasms
15
Fallopian Tube Neoplasms
15
Sarcoma
13
Bile Duct Neoplasms
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Hodgkin Disease
10
Lymphoma
9
Uterine Cervical Neoplasms
8
Adenocarcinoma
8
Stomach Neoplasms
7
Lymphoma, Non-Hodgkin
7
Endometrial Neoplasms
7
Nasopharyngeal Neoplasms
6
Interventions
Cyclophosphamide
5
fludarabine
4
fludarabine phosphate
3
acalabrutinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
pembrolizumab
1
obinutuzumab
1
ibrutinib
1
Vincristine
1
Prednisone
1
Doxorubicin
1
CA-4948
1
Bone Marrow Transplantation
1
ARQ531
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphatic Diseases
×
Gemcitabine
×
1 year
×
Clear all
No trials found.